I’m not against GLP-1s. They’re bioidentical peptides your body recognizes.
But the issue isn’t the medication — it’s the monitoring.
If you’re losing muscle mass instead of fat, that’s not metabolic progress.
That’s long-term instability.
When used, GLP-1s should be short-term, structured, and paired with body composition tracking — not just scale weight.
Fat loss protects health.
Muscle loss compromises it.
Systems over symptoms. Always.
#RootCauseMedicine
#SystemsOverSymptoms
#MetabolicHealth
#HormoneBalance
#FunctionalMedicine























